The Cost-Utility of Magnetic Resonance Imaging for Breast Cancer in BRCA1 Mutation Carriers Aged 30–49

The Cost-Utility of Magnetic Resonance Imaging for Breast Cancer in BRCA1 Mutation Carriers Aged 30–49

Recent evidence has investigated the costeffectiveness of magnetic resonance imaging (MRI) in younger women with a BRCA1 mutation. However, this evidence has not been contrasted with existing cost-effectiveness standards to determine whether screening is appropriate, given limited societal resourc...

Full description

Bibliographic Details
Main Authors: Norman, Richard, Evans, D., Easton, D., Young, K.
Format: Journal Article
Published: Springer 2007
Subjects:
Cost-utility
Mammography
MRI
Surveillance
BRCA1
Online Access:http://www.springer.com/economics/policy/journal/10198
http://hdl.handle.net/20.500.11937/8246

Internet

http://www.springer.com/economics/policy/journal/10198
http://hdl.handle.net/20.500.11937/8246

Similar Items